JP2015526407A - 増量剤を用いた失禁を安定的に治療する方法 - Google Patents

増量剤を用いた失禁を安定的に治療する方法 Download PDF

Info

Publication number
JP2015526407A
JP2015526407A JP2015520158A JP2015520158A JP2015526407A JP 2015526407 A JP2015526407 A JP 2015526407A JP 2015520158 A JP2015520158 A JP 2015520158A JP 2015520158 A JP2015520158 A JP 2015520158A JP 2015526407 A JP2015526407 A JP 2015526407A
Authority
JP
Japan
Prior art keywords
treatment
administered
subject
bulking agent
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015520158A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015526407A5 (enExample
Inventor
フランクリン，ハワード
Original Assignee
サリックス ファーマスーティカルズ，リミテッド
サリックス ファーマスーティカルズ，リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サリックス ファーマスーティカルズ，リミテッド, サリックス ファーマスーティカルズ，リミテッド filed Critical サリックス ファーマスーティカルズ，リミテッド
Publication of JP2015526407A publication Critical patent/JP2015526407A/ja
Publication of JP2015526407A5 publication Critical patent/JP2015526407A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2015520158A 2012-06-28 2013-03-07 増量剤を用いた失禁を安定的に治療する方法 Pending JP2015526407A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261665846P 2012-06-28 2012-06-28
US61/665,846 2012-06-28
US201261731774P 2012-11-30 2012-11-30
US61/731,774 2012-11-30
PCT/US2013/029542 WO2014003834A1 (en) 2012-06-28 2013-03-07 Method of stably treating incontinence using a bulking agent

Publications (2)

Publication Number Publication Date
JP2015526407A true JP2015526407A (ja) 2015-09-10
JP2015526407A5 JP2015526407A5 (enExample) 2016-04-21

Family

ID=49778744

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015520158A Pending JP2015526407A (ja) 2012-06-28 2013-03-07 増量剤を用いた失禁を安定的に治療する方法

Country Status (4)

Country Link
US (2) US20140005142A1 (enExample)
EP (1) EP2866813A4 (enExample)
JP (1) JP2015526407A (enExample)
WO (1) WO2014003834A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025057438A1 (ja) * 2023-09-13 2025-03-20 昌毅 本田 肛門狭窄化治療法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102072592B1 (ko) * 2012-09-24 2020-02-03 삼성전자 주식회사 ｅＵＩＣＣ의 식별자 관리 방법 및 그 장치
KR102208633B1 (ko) * 2013-11-01 2021-01-28 삼성전자 주식회사 단말에서 시스템 프레임 번호를 획득하기 위한 방법, 단말 및 이동 통신 시스템
EP2934039B1 (en) * 2014-04-15 2019-03-20 Telefonaktiebolaget LM Ericsson (publ) Technique for event reporting
CN107890497A (zh) * 2017-11-30 2018-04-10 孙铭岐 一种治疗家禽脱肛的药膏

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005272578A1 (en) * 2004-08-13 2006-02-23 Angiotech International Ag Compositions and methods using hyaluronic acid and hyluronidase inhibitors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GRAF, W. ET AL., THE LANCET, vol. 377, no. 9770, JPN6016042777, 19 March 2011 (2011-03-19), pages 997 - 1003, ISSN: 0003435086 *
HUSSAIN, Z.I. ET AL., BR. J. SURG., vol. 98, no. 11, JPN6016042775, November 2011 (2011-11-01), pages 1526 - 1536, ISSN: 0003435085 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025057438A1 (ja) * 2023-09-13 2025-03-20 昌毅 本田 肛門狭窄化治療法

Also Published As

Publication number Publication date
EP2866813A1 (en) 2015-05-06
US20140045788A1 (en) 2014-02-13
EP2866813A4 (en) 2016-03-02
WO2014003834A1 (en) 2014-01-03
US20140005142A1 (en) 2014-01-02

Similar Documents

Publication Publication Date Title
RU2207845C2 (ru) Твердая лекарственная форма пролонгированного действия для парентерального введения и способ ее получения
US12343454B2 (en) Hydrogels formed in situ and composition design for intrauterine use
CA2760802C (en) Low frequency glatiramer acetate therapy
US5866554A (en) Compositions for prevention of inflammation and adhesion formation and uses thereof
JP2011518180A (ja) クロニジンを含んでなる、術後疼痛を治療するための方法及び組成物
JP2008509935A (ja) ヒアルロン酸およびヒアルロン酸インヒビターを用いる組成物および方法
JP2015526407A (ja) 増量剤を用いた失禁を安定的に治療する方法
US20250177295A1 (en) Single solution hydrogels with covalent bonding formed in situ, composition design and medical procedures using the hydrogels
JP2008520392A (ja) 天然ポリマーの粘弾性組成物
US9017709B2 (en) Composition comprising polymeric, water-insoluble, anionic particles, processes and uses
KR102312643B1 (ko) 방광염을 치료하기 위해 저장 안정성이 증가된, 콘드로이틴 설페이트 (20 mg/ml), 히알루론산 (16 mg/ml) 및 포스페이트 버퍼 (ph 6.1 내지 7.9)를 함유하며 방광 점적 주입 조성물
KR20230107830A (ko) 인시튜로 형성되는 하이드로겔의 배치와 같은 자궁내 유체 교환을 위한 자궁경부를 통한 액세스 시스템
CN114984252A (zh) 泊洛沙姆在体内超声耦合剂中的应用及超声耦合剂
US20210154302A1 (en) Injectable composition
US11369667B2 (en) Collagenase clostridium histolyticum for treatment of bladder dysfunction
CN116507330A (zh) 用于子宫内使用的原位形成的水凝胶和组合物设计
CN117715661A (zh) 用于nirf成像的普地沙铵
CN1972717A (zh) 二元热胶凝组合物
Kharadi et al. Effect of partial fistulectomy with ksharasootra application in the management of bhagandara (fistula-in-ano)-A case report
RU2629717C2 (ru) Способ малоинвазивного лечения недержания мочи
Sharpe et al. Sacral nerve stimulation for the management of faecal incontinence
Wyman et al. Poloxamer-based Hydrogel for Vaginal Wound Healing

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150217

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20150217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160302

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160302

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161108

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170508

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170523